Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Positive Safety Results For Dendreon's Prostate Drug

Shares of Dendreon Corp. (Nasdaq: DNDN) rocketed $10.21 to $17.51 after the biotechnology company announced positive safety results for its prostate cancer drug treatment.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.